Targacept, Inc. (TRGT) to Report Fourth Quarter and 2012 Financial Results on February 13, 2013  
2/6/2013 7:00:56 AM

Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that it will report financial results for the fourth quarter and year ended December 31, 2012 on Wednesday, February 13, 2013, after the U.S. financial markets close.